Clinical trial
Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic…
NCT00159341 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00159341 |
|---|---|
| Title | Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
| Official title | Cigarette Smoke Nasal and Whole Blood Challenge in Patients With COPD |
| Lead sponsor | Imperial College London, Other |
| Collaborators | Millennium Pharmaceuticals, Inc. Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Diseases, Obstructive |
| Intervention type | Procedure |
| Interventions | Nasal lavage, Nasal filter paper, Blood sampling |
| Enrollment | 16 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 14, 2023 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: